- A coalition of military veterans’ organizations is joining a growing number of entities encouraging the U.S. DEA to reschedule cannabis
- The call to reschedule cannabis has gained momentum since the U.S. HHS sent a letter to the DEA supporting the change
- Operating as MedCana, Software Effective Solutions has five divisions focused on pharmaceutical cannabis production
A growing number of organizations are calling for the rescheduling of cannabis from a Schedule I substance per the Controlled Substances Act (“CSA”) to a Schedule III substance. The most recent group to voice is support of the change is a coalition of military veterans (https://cnw.fm/rbI0F). Companies operating in the cannabis space, including Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ), are paying close attention to the mounting demand because the rescheduling would significantly change the landscape.
“A coalition of military veterans’ organizations is pushing President Joe Biden to ensure that the ongoing administrative review into marijuana’s scheduling status is completed in a ‘timely manner’ and also take steps to ‘counter’ misinformation while pursuing broader reform,” reported a recent Marijuana Moment article. “In a letter sent to the president last week, multiple veterans-focused groups expressed appreciation for his directive initiating the marijuana review last year, which led the U.S. Department of Health and Human Services (‘HHS’) to recommend that cannabis be moved from Schedule I to Schedule III of the Controlled Substances Act.”
The article quoted a letter from the group noting that “this process represents a significant opportunity for our nation to lead with science over fear, and begin righting the wrongs of prohibition. . . . The actions taken by your administration and HHS have been historic, and lay the groundwork for the significant work ahead, including the need to ensure that the Drug Enforcement Administration (‘DEA’) expeditiously accepts the scientific and medically founded recommendation.”
The call for cannabis rescheduling on the CSA list is not new, but it has gained momentum since the U.S. HHS sent a brief letter to the head of the U.S. Drug Enforcement Administration. “The letter, obtained via Freedom of Information Act (‘FOIA’) request by Law360 reporter Sam Reisman, confirmed certain previously reported details such as the date of the correspondence, August 29, [2023,] and the author, HHS Assistant Secretary for Health Rachel Levine,” reported Marijuana Moment (https://cnw.fm/GSapR).
“But it was redacted to exclude the substance of the message such as the scheduling recommendation itself, as well as the scientific review portion that was attached to the letter,” the article continued. However, “HHS is believed to have advised DEA to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (‘CSA’), and the law enforcement agency is now carrying out its own review before making a final determination.”
A change in the rescheduling would almost certainly benefit Software Effective Solutions, a global infrastructure and holding company in the cannabis industry. Operating as MedCana, the company currently has five divisions focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.
MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. The company is committed to building the technology, laboratories, growing facilities and scientific teams needed to provide premium pharmaceutical-grade cannabis extracts to the world.
For more information, visit the company’s website at www.MedCana.net.
NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://cnw.fm/SFWJ
CBDWire (“CBDW”) is a specialized communications platform with a focus on CBD related news and updates in the cannabidiol (“CBD”) sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled recognition and brand awareness.
CBDW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CBDWire, text “CBDWire” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CBDWire.com
CBDWire is powered by IBN